Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

LAG-3 Antagonists

Apr 04, 2022

LAG 3: A Promising Next Generation Cancer Immunotherapy

Jan 21, 2016

LAG-3 Antagonists, TIM-3 Antagonists; OX40 Agonists- Pipeline Insights, 2016 – A DelveInsight Report

Newsletter/Whitepaper